Submission for OMB Review; 30-Day Comment Request; The Agricultural Health Study: A Prospective Cohort Study of Cancer and Other Diseases Among Men and Women in Agriculture (NIEHS), 23737-23739 [2016-09296]

Download as PDF 23737 Federal Register / Vol. 81, No. 78 / Friday, April 22, 2016 / Notices Estimates of annualized total hour burden are summarized in Table A.12– 1.4 Below. Number of respondents Type of respondent Number of responses per respondent Participants ...................................................................................................... Non-Participants .............................................................................................. 4580 3030 1 1 Totals ........................................................................................................ 7610 Average time per response (in hours) Total annual burden hour 90/60 15/60 2 7,653 729 8,382 (Note: reported and calculated numbers differ slightly due to rounding.) Dated: April 18, 2016. Valery Gheen, NHLBI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2016–09313 Filed 4–21–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive License: The Development of AntiCD70 Chimeric Antigen Receptors (CARs) for the Treatment of Chronic Myelogenous Leukemia AGENCY: National Institutes of Health, HHS. ACTION: Notice. This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Dedalus Pharma, LLC (‘‘Dedalus’’) located in Maryland, USA. mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: Intellectual Property United States Provisional Patent Application No. 62/088,882, filed December 8, 2014, entitled ‘‘Anti-CD70 Chimeric Antigen Receptors’’ [HHS Reference No. E–021–2015/0–US–01]; and PCT Application No. PCT/US2015/ 025047 filed April 9, 2015 entitled ‘‘Anti-CD70 Chimeric Antigen Receptors’’ [HHS Reference No. E–021– 2015/0–PCT–02]. The patent rights in these inventions have been assigned to the government of the United States of America. The patent rights in these inventions have been assigned to the government of the United States of America. The prospective exclusive license territory may be worldwide and the field of use may be limited to the development and commercialization of CD70 chimeric antigen receptor (CAR)-based autologous peripheral blood T cell VerDate Sep<11>2014 20:03 Apr 21, 2016 Jkt 238001 therapy products as set forth in the Licensed Patent Rights for the treatment of chronic myelogenous leukemia in humans. DATES: Only written comments and/or applications for a license which are received by the Technology Transfer Center at the National Cancer Institute on or before May 9, 2016 will be considered. ADDRESSES: Requests for copies of the patent application, inquiries, and comments relating to the contemplated exclusive license should be directed to: Andrew Burke, Ph.D., Licensing and Patenting Manager, Technology Transfer Center, National Cancer Institute, 9609 Medical Center Drive, MSC 9702, Rockville, MD 20852; Telephone: (240) 276–5484; Email: andy.burke@nih.gov. SUPPLEMENTARY INFORMATION: The present invention describes chimeric antigen receptors (CARs) targeting CD70. CARs are hybrid proteins comprised of extracellular antigen binding domains and intracellular signaling domains designed to activate the cytotoxic functions of CARtransduced T cells upon antigen stimulation. CD70 is a co-stimulatory molecule that provides proliferative and survival cues to competent cells upon binding to its cognate receptor, CD27. Its expression is primarily restricted to activated lymphoid cells; however, recent research has demonstrated that several cancers, including renal cell carcinoma, glioblastoma, non-Hodgkin’s lymphoma, and chronic myelogenous leukemia also express CD70 under certain circumstances. Due to its limited expression in normal tissues, CARs targeting CD70 may be useful in adoptive cell therapy protocols for the treatment of select cancers. The prospective exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR part 404. The prospective exclusive license may be granted unless within fifteen (15) days from the date of this published notice, the NCI receives written evidence and PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR part 404. Complete applications for a license in an appropriate field of use that are timely filed in response to this notice will be treated as objections to the grant of the contemplated exclusive license. Comments and objections submitted to this notice will not be made available for public inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: April 18, 2016. Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute. [FR Doc. 2016–09324 Filed 4–21–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; The Agricultural Health Study: A Prospective Cohort Study of Cancer and Other Diseases Among Men and Women in Agriculture (NIEHS) Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on November 27, 2015, Pages 74115–74116, and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information SUMMARY: E:\FR\FM\22APN1.SGM 22APN1 23738 Federal Register / Vol. 81, No. 78 / Friday, April 22, 2016 / Notices collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@ omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. DATES: Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments or request more information on the proposed project contact: Dale Sandler, Ph.D., Chief, Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, 111 T.W. Alexander Drive, P.O. Box 12233, MD A3–05, Research Triangle Park, NC 27709, or call non-toll-free number 919–541–4668, or email your request, including your address to: sandler@niehs.nih.gov. Formal requests for additional plans and instruments must be requested in writing. from occupational and environmental exposures in the agricultural environment. Secondary objectives include evaluating biological markers that may be associated with agricultural exposures and risk of certain types of cancer. Phase IV questionnaire data are collected by using self-administered computer assisted web survey (CAWI); self-administered paper-and-pen (Paper/ pen); or an interviewer administered computer assisted telephone interview (CATI) and in-person interview (CAPI) systems for telephone screeners and home visit interviews, respectively. Some respondents are also asked to participate in the collection of biospecimens and environmental samples, including blood, urine, buccal cells (loose cells from the respondent’s mouth), and vacuum dust. The findings will provide valuable information concerning the potential link between agricultural exposures and cancer and other chronic diseases among Agricultural Health Study cohort members, and this information may be generalized to the entire agricultural community. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 11,440. Proposed Collection: The Agricultural Health Study: A Prospective Cohort Study of Cancer and Other Diseases Among Men and Women in Agriculture, 0925–0406 (Expiration Date 9/30/2016, REVISION), National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of this information collection is to request new components as part of the ongoing Study of Biomarkers of Exposures and Effects in Agriculture (BEEA), as well as continue and complete phase IV (2013– 2016) of the Agricultural Health Study (AHS) and continue buccal cell collection. Phase IV will continue to update the occupational and environmental exposure information as well as medical history information for licensed pesticide applicators and their spouses enrolled in the AHS. The new BEEA components are a control respondent group, and a smartphone application (app), along with new sample collection (buccal cell and air monitoring samples). The new components will use similar procedures to ones already employed on the BEEA study, as well as other NCI studies. The primary objectives of the study are to determine the health effects resulting ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Private and Commercial Applicators and Spouses. Private and Commercial Applicators and Spouses. Private and Commercial Applicators and Spouses. Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ mstockstill on DSK4VPTVN1PROD with NOTICES Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ Private Applicators ................ VerDate Sep<11>2014 19:18 Apr 21, 2016 Number of respondents Form name Number of responses per respondent Average time per response (in hours) Total annual burden hours IA/NC Scripts for Verbal Consent for Buccal 100 1 3/60 5 IA/NC Written Consent for Buccal ............... 100 1 5/60 8 Buccal Follow-up Scripts (as needed): Reminder, Missing Consent, or Damaged/ Missing Sample. BEEA CATI Screening Script for RSG, REG or AMG Eligibility. IA/NC BEEA Consent for RSG Home Visit or REG Home Visit or AMG Home Visit. IA/NC BEEA RSG Pre-Visit Show Card ...... IA/NC BEEA RSG Paper/Pen Dust Questionnaire. BEEA RSG Pre-Home Visit Script ............... BEEA RSG Home Visit CAPI, Blood, Buccal cell, Urine & Dust. IA/NC BEEA REG Pre-Visit Show Card ...... IA/NC BEEA REG Paper/Pen Dust Questionnaire. BEEA REG Pre-Home Visit Script ............... BEEA REG Home Visit CAPI, Blood, Buccal cell, Urine & Dust. IA/NC BEEA REG Post-Exposure Scheduling Script. IA/NC BEEA AMG Pre-Visit Show Card ...... IA/NC BEEA AMG Paper/Pen Dust Questionnaire. BEEA AMG Pre-Home Visit Script .............. BEEA AMG Home Visit CAPI, Blood, Urine, Buccal cell & Dust. 30 1 2/60 1 480 1 20/60 160 196 1 5/60 16 160 160 1 1 5/60 10/60 13 27 160 160 1 1 2/60 90/60 5 240 20 20 3 3 5/60 10/60 5 10 20 20 3 3 2/60 90/60 2 90 20 1 2/60 1 16 16 2 2 5/60 10/60 3 5 16 16 2 2 2/60 90/60 1 48 Jkt 238001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\22APN1.SGM 22APN1 23739 Federal Register / Vol. 81, No. 78 / Friday, April 22, 2016 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Type of respondent Form name Private Applicators ................ Private Applicators ................ Controls ................................. Controls ................................. Controls ................................. Controls ................................. Controls ................................. Controls ................................. IA/NC BEEA Consent for AMG Farm Visit .. BEEA Pre-Farm Visit Script ......................... BEEA CATI Control Eligibility Script ............ IA/NC BEEA Control Home Visit Consent ... IA/NC BEEA Pre-Visit Show Card ............... IA/NC BEEA Paper/Pen Dust Questionnaire BEEA REG Pre-Visit Script .......................... BEEA Control Home Visit CAPI, Blood, Buccal cell, Urine, & Dust. ‘Life in a Day’ Smartphone App Consent and Setup. ‘Life in a Day’ Smartphone Application ........ Phase IV Follow-up CAWI, CATI, or Paper/ pen. Phase IV Follow-up CAWI, CATI, or Paper/ pen. Phase IV Follow-up CAWI, CATI, or Paper/ pen. Private Applicators ................ Private Applicators ................ Private Applicators ................ Spouses ................................ Proxy ..................................... Total ............................... ....................................................................... Dated: April 18, 2016. Jane M. Lambert, Project Clearance Liaison, NIEHS. [FR Doc. 2016–09296 Filed 4–21–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee F—Institutional Training and Education. Date: June 14, 2016. Time: 12:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850, (Telephone Conference Call). VerDate Sep<11>2014 19:18 Apr 21, 2016 Jkt 238001 5/60 2/60 20/60 5/60 5/60 10/60 2/60 90/60 1 1 72 6 6 11 2 101 78 1 20/60 26 78 13,855 30 1 10/60 25/60 390 5,773 10,201 1 25/60 4,250 635 1 15/60 159 27,139 29,641 ........................ 11,438 [FR Doc. 2016–09315 Filed 4–21–16; 8:45 am] Frm 00066 Fmt 4703 Sfmt 4703 Total annual burden hours 1 2 1 1 1 1 1 1 Dated: April 18, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. PO 00000 Average time per response (in hours) 16 16 215 67 67 67 67 67 Contact Person: Timothy C. Meeker, M.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W624, Bethesda, MD 20892–9750, 240–276– 6464, meekert@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54). Date: June 15–16, 2016. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Yisong Wang, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W240, Bethesda, MD 20892–9750, 240–276–7157, yisong.wang@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) BILLING CODE 4140–01–P Number of responses per respondent DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0123] Agency Information Collection Activities: Regulations Relating to Recordation and Enforcement of Trademarks and Copyrights U.S. Customs and Border Protection, Department of Homeland Security. ACTION: 30-Day notice and request for comments; Extension of an existing collection of information. AGENCY: U.S. Customs and Border Protection (CBP) of the Department of Homeland Security will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act: Regulations Relating to Recordation and Enforcement of Trademarks and Copyrights (Part 133 of the CBP Regulations). This is a proposed extension of an information collection that was previously approved. CBP is proposing that this information collection be extended with no change to the burden hours or to the information collected. This document is published to obtain comments from the public and affected agencies. DATES: Written comments should be received on or before May 23, 2016 to be assured of consideration. ADDRESSES: Interested persons are invited to submit written comments on this proposed information collection to SUMMARY: E:\FR\FM\22APN1.SGM 22APN1

Agencies

[Federal Register Volume 81, Number 78 (Friday, April 22, 2016)]
[Notices]
[Pages 23737-23739]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09296]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; The 
Agricultural Health Study: A Prospective Cohort Study of Cancer and 
Other Diseases Among Men and Women in Agriculture (NIEHS)

SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Health (NIH), has 
submitted to the Office of Management and Budget (OMB) a request for 
review and approval of the information collection listed below. This 
proposed information collection was previously published in the Federal 
Register on November 27, 2015, Pages 74115-74116, and allowed 60-days 
for public comment. No public comments were received. The purpose of 
this notice is to allow an additional 30 days for public comment. The 
National Institute of Environmental Health Sciences (NIEHS), National 
Institutes of Health, may not conduct or sponsor, and the respondent is 
not required to respond to, an information

[[Page 23738]]

collection that has been extended, revised, or implemented on or after 
October 1, 1995, unless it displays a currently valid OMB control 
number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974, 
Attention: NIH Desk Officer.

DATES: Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments or request more information on the 
proposed project contact: Dale Sandler, Ph.D., Chief, Epidemiology 
Branch, National Institute of Environmental Health Sciences, NIH, 111 
T.W. Alexander Drive, P.O. Box 12233, MD A3-05, Research Triangle Park, 
NC 27709, or call non-toll-free number 919-541-4668, or email your 
request, including your address to: sandler@niehs.nih.gov. Formal 
requests for additional plans and instruments must be requested in 
writing.
    Proposed Collection: The Agricultural Health Study: A Prospective 
Cohort Study of Cancer and Other Diseases Among Men and Women in 
Agriculture, 0925-0406 (Expiration Date 9/30/2016, REVISION), National 
Institute of Environmental Health Sciences (NIEHS), National Institutes 
of Health (NIH).
    Need and Use of Information Collection: The purpose of this 
information collection is to request new components as part of the 
ongoing Study of Biomarkers of Exposures and Effects in Agriculture 
(BEEA), as well as continue and complete phase IV (2013-2016) of the 
Agricultural Health Study (AHS) and continue buccal cell collection. 
Phase IV will continue to update the occupational and environmental 
exposure information as well as medical history information for 
licensed pesticide applicators and their spouses enrolled in the AHS. 
The new BEEA components are a control respondent group, and a 
smartphone application (app), along with new sample collection (buccal 
cell and air monitoring samples). The new components will use similar 
procedures to ones already employed on the BEEA study, as well as other 
NCI studies. The primary objectives of the study are to determine the 
health effects resulting from occupational and environmental exposures 
in the agricultural environment. Secondary objectives include 
evaluating biological markers that may be associated with agricultural 
exposures and risk of certain types of cancer. Phase IV questionnaire 
data are collected by using self-administered computer assisted web 
survey (CAWI); self-administered paper-and-pen (Paper/pen); or an 
interviewer administered computer assisted telephone interview (CATI) 
and in-person interview (CAPI) systems for telephone screeners and home 
visit interviews, respectively. Some respondents are also asked to 
participate in the collection of biospecimens and environmental 
samples, including blood, urine, buccal cells (loose cells from the 
respondent's mouth), and vacuum dust. The findings will provide 
valuable information concerning the potential link between agricultural 
exposures and cancer and other chronic diseases among Agricultural 
Health Study cohort members, and this information may be generalized to 
the entire agricultural community.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 11,440.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
      Type of respondent            Form name        Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)     burden hours
----------------------------------------------------------------------------------------------------------------
Private and Commercial          IA/NC Scripts                100               1            3/60               5
 Applicators and Spouses.        for Verbal
                                 Consent for
                                 Buccal.
Private and Commercial          IA/NC Written                100               1            5/60               8
 Applicators and Spouses.        Consent for
                                 Buccal.
Private and Commercial          Buccal Follow-up              30               1            2/60               1
 Applicators and Spouses.        Scripts (as
                                 needed):
                                 Reminder,
                                 Missing
                                 Consent, or
                                 Damaged/Missing
                                 Sample.
Private Applicators...........  BEEA CATI                    480               1           20/60             160
                                 Screening
                                 Script for RSG,
                                 REG or AMG
                                 Eligibility.
Private Applicators...........  IA/NC BEEA                   196               1            5/60              16
                                 Consent for RSG
                                 Home Visit or
                                 REG Home Visit
                                 or AMG Home
                                 Visit.
Private Applicators...........  IA/NC BEEA RSG               160               1            5/60              13
                                 Pre-Visit Show
                                 Card.
Private Applicators...........  IA/NC BEEA RSG               160               1           10/60              27
                                 Paper/Pen Dust
                                 Questionnaire.
Private Applicators...........  BEEA RSG Pre-                160               1            2/60               5
                                 Home Visit
                                 Script.
Private Applicators...........  BEEA RSG Home                160               1           90/60             240
                                 Visit CAPI,
                                 Blood, Buccal
                                 cell, Urine &
                                 Dust.
Private Applicators...........  IA/NC BEEA REG                20               3            5/60               5
                                 Pre-Visit Show
                                 Card.
Private Applicators...........  IA/NC BEEA REG                20               3           10/60              10
                                 Paper/Pen Dust
                                 Questionnaire.
Private Applicators...........  BEEA REG Pre-                 20               3            2/60               2
                                 Home Visit
                                 Script.
Private Applicators...........  BEEA REG Home                 20               3           90/60              90
                                 Visit CAPI,
                                 Blood, Buccal
                                 cell, Urine &
                                 Dust.
Private Applicators...........  IA/NC BEEA REG                20               1            2/60               1
                                 Post-Exposure
                                 Scheduling
                                 Script.
Private Applicators...........  IA/NC BEEA AMG                16               2            5/60               3
                                 Pre-Visit Show
                                 Card.
Private Applicators...........  IA/NC BEEA AMG                16               2           10/60               5
                                 Paper/Pen Dust
                                 Questionnaire.
Private Applicators...........  BEEA AMG Pre-                 16               2            2/60               1
                                 Home Visit
                                 Script.
Private Applicators...........  BEEA AMG Home                 16               2           90/60              48
                                 Visit CAPI,
                                 Blood, Urine,
                                 Buccal cell &
                                 Dust.

[[Page 23739]]

 
Private Applicators...........  IA/NC BEEA                    16               1            5/60               1
                                 Consent for AMG
                                 Farm Visit.
Private Applicators...........  BEEA Pre-Farm                 16               2            2/60               1
                                 Visit Script.
Controls......................  BEEA CATI                    215               1           20/60              72
                                 Control
                                 Eligibility
                                 Script.
Controls......................  IA/NC BEEA                    67               1            5/60               6
                                 Control Home
                                 Visit Consent.
Controls......................  IA/NC BEEA Pre-               67               1            5/60               6
                                 Visit Show Card.
Controls......................  IA/NC BEEA Paper/             67               1           10/60              11
                                 Pen Dust
                                 Questionnaire.
Controls......................  BEEA REG Pre-                 67               1            2/60               2
                                 Visit Script.
Controls......................  BEEA Control                  67               1           90/60             101
                                 Home Visit
                                 CAPI, Blood,
                                 Buccal cell,
                                 Urine, & Dust.
Private Applicators...........  `Life in a Day'               78               1           20/60              26
                                 Smartphone App
                                 Consent and
                                 Setup.
Private Applicators...........  `Life in a Day'               78              30           10/60             390
                                 Smartphone
                                 Application.
Private Applicators...........  Phase IV Follow-          13,855               1           25/60           5,773
                                 up CAWI, CATI,
                                 or Paper/pen.
Spouses.......................  Phase IV Follow-          10,201               1           25/60           4,250
                                 up CAWI, CATI,
                                 or Paper/pen.
Proxy.........................  Phase IV Follow-             635               1           15/60             159
                                 up CAWI, CATI,
                                 or Paper/pen.
                                                 ---------------------------------------------------------------
    Total.....................  ................          27,139          29,641  ..............          11,438
----------------------------------------------------------------------------------------------------------------


    Dated: April 18, 2016.
Jane M. Lambert,
Project Clearance Liaison, NIEHS.
[FR Doc. 2016-09296 Filed 4-21-16; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.